EUVIMEDEUVIMED entdecken
Crossref

Lipid-Based Nanocarriers (SLNs, NLCs, Liposomes): Design, Optimization, and Therapeutic Applications

Swapnali V. Dharanguttikar, Bhushan Varne, Rushikesh B. Basugade, Sachin S. Mali, Suhana A. Mujawar, Kavita D. Patil

International Journal of Drug Delivery Technology · 05.05.2026 · 16 (24s)

DOI: 10.25258/ijddt.16.24s.31 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.05.2026. Verfasst von Swapnali V. Dharanguttikar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid-based nanocarriers have emerged as a versatile and efficient platform for improving drug delivery, particularly for poorly water-soluble and unstable therapeutic agents. Among these systems, liposomes, solid lipid nanoparticles (SLNs), and nanostructured lipid carriers (NLCs) have gained significant attention due to their biocompatibility, biodegradability, and ability to enhance drug solubility and bioavailability. Liposomes, composed of phospholipid bilayers, enable the encapsulation of both hydrophilic and lipophilic drugs, while SLNs provide a solid lipid matrix for controlled drug release. NLCs, developed as second-generation carriers, offer improved drug loading capacity and stability by incorporating both solid and liquid lipids. The design and optimization of these nanocarriers involve careful selection of lipids, surfactants, and preparation techniques to achieve desired physicochemical properties such as particle size, stability, and release profile. Advanced characterization methods are essential to ensure formulation quality and performance. Lipid-based nanocarriers have demonstrated wide applications in cancer therapy, oral delivery, topical formulations, and gene delivery. Despite their promising potential, challenges related to stability, scalability, and regulatory approval remain. Overall, lipid-based nanocarriers represent a promising approach for enhancing therapeutic efficacy and advancing targeted drug delivery.

Zitieren

APA

Dharanguttikar, S. V., Varne, B., Basugade, R. B., Mali, S. S., Mujawar, S. A., & Patil, K. D. (2026). Lipid-Based Nanocarriers (SLNs, NLCs, Liposomes): Design, Optimization, and Therapeutic Applications. International Journal of Drug Delivery Technology, 16(24s). https://doi.org/10.25258/ijddt.16.24s.31

Vancouver

Dharanguttikar SV, Varne B, Basugade RB, Mali SS, Mujawar SA, Patil KD. Lipid-Based Nanocarriers (SLNs, NLCs, Liposomes): Design, Optimization, and Therapeutic Applications. International Journal of Drug Delivery Technology. 2026;16(24s). doi:10.25258/ijddt.16.24s.31

BibTeX
@article{Dharanguttikar2026,
  author = {Dharanguttikar, Swapnali V. and Varne, Bhushan and Basugade, Rushikesh B. and Mali, Sachin S. and Mujawar, Suhana A. and Patil, Kavita D.},
  title = {Lipid-Based Nanocarriers (SLNs, NLCs, Liposomes): Design, Optimization, and Therapeutic Applications},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {24s},
  doi = {10.25258/ijddt.16.24s.31}
}
Kostenlos starten →